Rafael Holdings, Inc.
RFL · XNYSCIK 1713863fmd_1BMNDMB66GPE8KB80G5JWQQ2BR制造业 · 医药制剂模板: 标准
覆盖范围: 2015年8月01日 至 2026年7月31日，共 40 个期间
| 项目 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 租金收入 | 1 | 1 | 1 | 2 | 0 | 0 | – | – | – | – |
| 营业总收入 | 6 | 4 | 5 | 5 | 1 | 0 | 0 | 1 | 1 | 1 |
| 净利息收入 | 0 | 0 | 0 | (0) | (0) | – | – | – | – | – |
| 营业成本 | – | – | – | – | 3 | 3 | – | 0 | – | – |
| 已实现投资收益（损失） | – | 0 | 0 | – | – | – | 0 | (0) | – | – |
| 毛利润 | – | – | – | – | (2) | (3) | – | 0 | – | – |
| 研发费用 | – | 1 | 1 | 2 | 5 | 9 | 6 | 4 | 13 | 24 |
| 销售、一般及管理费用 | 4 | 6 | 9 | 9 | 17 | 17 | – | – | – | – |
| 出售房地产收益 | – | – | – | – | 1 | – | 1 | – | – | – |
| 薪酬与福利 | 1 | – | – | – | – | – | – | – | – | – |
| 营业利润 | 0 | (4) | (7) | (8) | (28) | (60) | (15) | (103) | (29) | (33) |
| 利息费用 | – | – | 0 | 0 | 0 | 0 | – | 0 | 1 | 0 |
| 其他营业外收入（支出） | – | – | – | – | – | – | – | 0 | 0 | 0 |
| 税前利润 | 0 | (4) | (5) | (7) | (23) | (140) | (9) | (67) | (33) | (28) |
| 所得税费用 | 0 | 8 | (0) | 0 | 0 | – | (0) | (3) | (3) | (0) |
| 持续经营净利润 | 0 | (12) | (5) | (7) | (23) | (141) | (9) | (65) | (31) | (28) |
| 净利润 | 0 | (12) | (5) | (11) | (23) | (125) | (2) | (34) | (31) | (30) |
| 归属于普通股股东的净利润 | – | – | – | – | (25) | (125) | (2) | (34) | – | – |